Quick Takeaways
- Gabriel Cohn has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $11,506.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Gabriel Cohn
- Location
- Bedford, MA
- Summary
- The estimated net worth of Gabriel Cohn is at least $11,506 dollars as of 12 Jan 2022. Gabriel Cohn is the Chief Medical Officer of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $11.5K.
- Signature
- /s/ W. Bradford Smith, Attorney-in-Fact for Gabriel Cohn
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Gabriel Cohn and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Homology Medicines, Inc. ($11,506).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Gabriel Cohn
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| QTTB | Homology Medicines, Inc. | Chief Medical Officer | $11,506 | 01 Jan 2022 |
Insider Transactions Reported by Gabriel Cohn:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.